NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026
NeurAxis, Inc., a medical technology company specializing in neuromodulation therapies, announced it will report its Q2 2026 financial results on August 11, 2026, prior to market open. The company also scheduled a conference call to discuss these results and provide a business update. NeurAxis focuses on its proprietary IB-Stim® PENFS technology, F…